An amendment that will impact regulations for testing the safety & efficacy of drugs and ingredients
Yesterday, the US Senate unanimously approved the FDA Modernization Act 2.0, which was previously approved by the Lower House. This new...
top of page
- Jul 7, 2022
Collaborative effort led by Marian Walhout spotlights worms as model for personalized medicine
Multidisciplinary collaboration develops C. elegans as a model for investigating metabolism variations between individuals Marian...
- Jun 9, 2022
US House passes legislation to end FDA animal testing mandate
FDA Modernization Act rider will spare animals, drive down drug prices and produce safer treatments and cures By EP News Bureau on June...
- Apr 1, 2022
New Approaches for Incorporating Genetic Diversity into Toxicity Testing
Our study aims to combine state-of-the art advances in microfluidics, computer vision, laboratory automation and a massively curated...
- Nov 20, 2020
First research completed on the whole-life toxicity of CBD
Canopy Growth Corporation and its medical division, Spectrum Therapeutics, have completed and published a new study on the long-term...
- Jun 3, 2020
New Approaches for Incorporating Genetic Diversity into Toxicity Testing
Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer’s Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed...
bottom of page